Your browser doesn't support javascript.
loading
: 20 | 50 | 100
1 - 2 de 2
1.
Pulmonology ; 29(5): 399-409, 2023.
Article En | MEDLINE | ID: mdl-37045743

RATIONALE: The six-minute walk test (6MWT) is a practical and simple field-based test to assess physical capacity. Several reference equations for six-minute walking distance (6MWD, m) exist, but have a number of limitations that decrease their clinical utility. In addition, no reference equations exist for the 6MWT-derived outcome six-minute walk work (6MWORK, kg.m). OBJECTIVES: To establish new reference equations for 6MWD and 6MWORK on a 20 m course using data from the population-based Canadian Cohort Obstructive Lung Disease study. METHODS AND MEASUREMENTS: A total of 335 participants without obstructive or restrictive pulmonary function, with normal self-reported health status, normal exercise capacity, and <30 pack years cigarette smoking history were selected to create a representative sample of Canadian adults aged ≥40 years. All participants performed two 6MWTs. Reference equations were derived using multiple regression analyses. MAIN RESULTS: On average, 6MWD and 6MWORK were 541±98 m and 41.3 ± 11.2 kg.m, respectively. All outcomes were significantly greater in males than females. Sex-specific reference equations were derived from the results of 6MWD and 6MWORK with an explained variance of 24 to 35%. CONCLUSIONS: This study established reference equations for 6MWD and 6MWORK on a 20 m course in Caucasian males and females aged ≥40 years with normal pulmonary function, self-reported health status and exercise capacity. These newly derived reference equations add value to the assessment of functional capacity in clinical practice.


Lung , Walking , Male , Female , Humans , Adult , Reference Values , Canada/epidemiology , Walk Test
2.
Expert Rev Respir Med ; 10(8): 927-33, 2016 08.
Article En | MEDLINE | ID: mdl-27227384

BACKGROUND: Unambiguously for inhaled products, PK measures are best suited for ensuring that the total systemic exposure is equivalent for two products but cannot provide regional information about lung deposition and structural changes. Functional respiratory imaging (FRI) has been demonstrated to be sensitive for distinguishing small but imperative differences related to a single treatment. METHODS: In this study FRI is used in 16 asthmatic patients to assess equivalence in regional deposition for two products (fluticasone/salmeterol, test and reference) by directly measuring regional functional and structural changes within the lungs following its administration. RESULTS: No differences were observed between the lung deposition patterns and the effects on lung structure and function of two products, having the same formulation and manufactured by different organizations using FRI. CONCLUSIONS: Results using FRI complement PK assessments. The added value of this approach to the conventional clinical methods could be significant.


Asthma/drug therapy , Asthma/metabolism , Bronchodilator Agents/pharmacokinetics , Fluticasone-Salmeterol Drug Combination/pharmacokinetics , Lung/metabolism , Aged , Asthma/diagnostic imaging , Bronchodilator Agents/administration & dosage , Cross-Over Studies , Double-Blind Method , Female , Fluticasone-Salmeterol Drug Combination/administration & dosage , Humans , Lung/diagnostic imaging , Male , Metered Dose Inhalers , Middle Aged , Tomography, X-Ray Computed
...